420 with CNW — Poll Finds That Majority of Biden Voters

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
337
420 with CNW — Poll Finds That Majority of Biden Voters Support Federal Cannabis Legalization

A new poll has discovered that a majority of people in America support letting states set their own marijuana policies, including the legalization of cannabis. The YouGov poll found that 7 in every 10 individuals who voted to elect President Joseph Biden support the nationwide legalization of cannabis, despite Biden’s opposition to the change in policy.

This survey emphasizes how unpopular cannabis prohibition is in the United States, with none of the demographics surveyed showing majority support for federal marijuana prohibition. The survey found that 25% of respondents felt that states needed to be able to decide whether or not to legalize cannabis with 45% admitting that they felt that marijuana needed to be legalized at the federal level. This figure makes up the majority of respondents who were in support of legalization.

Of those surveyed, only 17% were still in support of cannabis prohibition, with the remaining percentage still undecided on the issue. The poll also found that 78% of Democrats were in favor of legalizing marijuana federally, with 16% of this number arguing that the decision needed to be left to the states. The remainder argued that the plant needed to be legalized at the national level.

The survey also found that 23% of Republicans were in favor of national legalization while about 35% preferred that it be the states’ call. In addition to this, the poll found that more than 30% of those who identified as Republicans were in favor of federal cannabis prohibition. Of those who identified as Independent, 14% supported federal prohibition while roughly 25% were in favor of states making the decision. Additionally, the survey discovered that vast majorities of all age demographics believed that cannabis needed to be legalized, either as a state decision or across the country.

The survey also asked respondents about their coronavirus vaccination status, finding that fully vaccinated individuals who had also received their booster shots were more likely to support nationwide legalization with almost 20% preferring that it be the states’ decision. Of the number that was vaccinated without the booster, 19% were in favor of cannabis prohibition while 30% were in favor of it being the states’ choice. The survey’s findings show that support for marijuana reform was lowest among the nonvaccinated cohort.

The survey also asked questions on same-sex marriages, sex work and abortion rights. The survey involved 1,500 adults in America and was conducted May 8–10 of this year. The survey’s results show the growing popularity of cannabis reform as more states regulate marijuana and move to end its prohibition by allowing companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) to operate within the markets established.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer




Cannabis Strategic Ventures, Inc (NUGS) Stock Research Links

NUGS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PROCEPT Faces Legal Storm Over Sales Practices Missteps

Updated Category News Views 1

Investors Take Aim: A Legal Showdown on the Horizon There's a brewing storm over at PROCEPT BioRobotics—ticker NASDAQ:PRCT if you're tracking. These folks are knee-deep in a securities class action lawsuit from investors who’ve taken a financial wallop. The lawsuits are triggered by allegations of shady sales techniques that artificially bumped up their unit sales...

Continue Reading
Carestream's Enhanced DRX-LC: Imaging Game Changer

Updated Category News Views 1

Rethinking Long-Length Imaging with Carestream The medical imaging sector just got a shot in the arm with Carestream Healthcare International's latest leap in technology. The DRX?LC Detector is not just a fancy update — it's a full-on revolution for long?length imaging. Forget the old days of piecing multiple exposures together, because this innovation simplifies...

Continue Reading
TECNO POVA 8 Pro 5G: Blending Speed with Style

Updated Category News Views 0

TECNO's Newest Launch: A Marriage of Luxurious Design and Performance This ain't just any phone—they've hitched a race car to your pocket. The TECNO POVA 8 Pro 5G Tonino Lamborghini Limited Edition makes a splash, promising to redefine what folks expect from a luxury-tier device, thanks to its endorsed partnership with the iconic Italian brand. But what's all this mean...

Continue Reading
Regeneron: Investors Face Class Action Over Study Flaws

Updated Category News Views 2

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Continue Reading
TCL's Energy Vision Unveiled at IFA 2026

Updated Category News Views 0

TCL's Forward-Thinking Approach at IFA 2026 IFA 2026 in Berlin got a jolt when TCL Industries and TCL Technology rolled out their ambitious plans under the banner "Inspiration Habitat." By blending cutting-edge smart devices with clean energy advancements, TCL is frantically waving red flags for anyone with an eye on future living trends. The Heartbeat of Inspiration...

Continue Reading
APX Bridges Crypto & Traditional Finance With New Credit Line

Updated Category News Views 0

The Future of Financial Bridging Now here's a scenario that might perk your ears up if you've ever toyed with digital assets: APX Lending is stepping up its game, bringing a regulated five-year revolving line of credit backed by Bitcoin and Ethereum to the world stage. It's like blending your grandma's tried-and-true savings approach with the whiz-bang allure of crypto. A...

Continue Reading
Yardi Virtuoso AI to Shine at CAIC 2026 Toronto

Updated Category News Views 3

The Scene in Toronto: Yardi's Big AI Showcase There's no denying it—Artificial Intelligence has muscled its way into practically every corner of the business world, and now it's making waves in real estate. Yardi, a familiar name in real estate tech circles, is gearing up to flaunt its Yardi Virtuoso Enterprise at the Canadian Apartment Investment Conference (CAIC) in...

Continue Reading
DeFi Technologies Gains More Time for Nasdaq Compliance

Updated Category News Views 1

DeFi Must Step Up To Meet Compliance Challenge Alright, folks, here's the scoop: DeFi Technologies just picked up another 180 days from Nasdaq to get its act together and hit that crucial one-buck minimum bid price. It's like getting extra time on a pop quiz you forgot to study for—useful, but no guarantee they'll pass. What Led to the Extra Time? These guys over at...

Continue Reading
Pentair Faces Class Action Over Fraud Allegations

Updated Category News Views 2

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

Continue Reading
ECRI Welcomes Safety Expert Meshkati to Its Board

Updated Category News Views 1

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

Continue Reading

Top 5 Most Recently Viewed Articles

Ascend Wellness Shares Financial Growth Highlights for 2024

Updated Category News Views 160

Ascend Wellness Holdings Financial Highlights AWH experienced significant growth with a reported net revenue of $562 million in the fiscal year, reflecting an 8% year-on-year increase. This growth highlights the company’s resilience and strategic direction in the evolving cannabis landscape. Positive Operational Metrics With adjustments made to enhance efficiency, AWH...

Continue Reading
New 5K Unity Run to Strengthen Community Bonds in Memphis

Updated Category News Views 230

Innovative Partnership Announced in Memphis The National Civil Rights Museum and Unite Memphis have joined forces to promote a powerful message rooted in healing, honor, and hope within the vibrant city of Memphis. This partnership marks a pivotal moment for Unite Memphis, which has impressively grown by 43% in participation last year as it enters its fourth anniversary....

Continue Reading
Ohio Removes CRNA Supervision for Better Care Access

Updated Category News Views 10

Ohio Paves New Paths in Anesthesia Care With a flick of the pen, Ohio made a significant change in its healthcare landscape, opting out of physician supervision requirements for Certified Registered Nurse Anesthetists (CRNAs). Governor Mike DeWine's decision marks Ohio as the 27th state to liberate CRNAs from an outdated mandate. This isn’t your typical shuffle of the...

Continue Reading
Infosys Partners with Google Cloud to Revolutionize AI Solutions

Updated Category News Views 384

Infosys and Google Cloud Collaboration Overview Infosys (NYSE: INFY), renowned for its next-generation digital services, has announced a groundbreaking collaboration with Google Cloud, creating a center of excellence dedicated to enterprise AI innovation. This initiative will leverage cutting-edge technologies, particularly Infosys Topaz, to develop transformative...

Continue Reading
Nucleome Therapeutics: A Shift in Scientific Leadership

Updated Category News Views 152

Nucleome Therapeutics just dropped a bombshell with the appointment of Dr. Michelle Morrow as their Chief Scientific Officer. This move could be a game changer, considering her hefty background in immunology and drug development. Dr. Morrow isn't just a fresh face; she's packing twenty years of experience under her belt, primarily shaping drug discovery strategies at...

Continue Reading